Torrent Pharmaceuticals Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 4,979 Cr, PAT Rs 534 Cr

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 Results FY27 announced on 23 October 2026, covering the company's financial performance for the July to September quarter. On that results date the company reported consolidated results showing revenue of Rs 4,979 Cr and PAT of Rs 534 Cr. The Torrent Pharmaceuticals Q2 Results FY27 stand out for a gap between sales and profit, with revenue up by half while net profit came in lower than last year.

Our results analysis of the Torrent Pharmaceuticals Q2 Results works through the reported figures, the business factors behind them, the outlook for the rest of the year and the risks to track. Each part builds on the numbers set out in the financial highlights below.

Click Here – Get Free Investment Predictions

Torrent Pharmaceuticals Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 4979 Cr	Rs 3302 Cr	+50.79% YoY
Operating Profit	Rs 1666 Cr	Rs 1083 Cr	+53.83% YoY
Net Profit (PAT)	Rs 534 Cr	Rs 591 Cr	-9.64% YoY

Source: company filing for Torrent Pharmaceuticals Q2 Results FY27, 23 October 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Torrent Pharmaceuticals Q2 Results: What Stands Out

• Revenue rose to Rs 4,979 Cr: a 50.79% YoY increase from Rs 3,302 Cr, adding Rs 1,677 Cr to the top line in a year.
• Net profit eased to Rs 534 Cr: PAT fell 9.64% from Rs 591 Cr, so YoY growth at the bottom line was negative this quarter.
• Operating Profit climbed to Rs 1,666 Cr: up 53.83% from Rs 1,083 Cr, slightly ahead of the pace of revenue growth.
• Net margin in Torrent Pharmaceuticals Q2 Results FY27: net profit margin narrowed to 10.7% from 17.9% in the comparison quarter.
• Key watch point: debt at 1.76 times total assets in FY26 is the balance sheet item the performance analysis keeps in view.

Torrent Pharmaceuticals Q2 Results FY27: Performance Analysis

The Torrent Pharmaceuticals Q2 Results FY27 split into two directions. Revenue grew 50.79% and Operating Profit grew 53.83%, yet net profit fell 9.64% to Rs 534 Cr. This divergence between the middle profit line and the bottom line is the defining feature of the quarter in any results analysis.

In absolute terms, Operating Profit increased by Rs 583 Cr while net profit declined by Rs 57 Cr. The filing figures confirm the gap between these two lines, and the Key Business Factors section lists the drivers the company data supports. The Torrent Pharmaceuticals Q2 Results therefore need to be read line by line rather than through revenue alone.

Investors tracking later quarterly results will look at whether YoY growth in revenue stays strong and whether net profit margin recovers from 10.7%. The Torrent Pharmaceuticals Q2 Results FY27 place the margin question at the centre, and the business factors explain what shaped the revenue side.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Sustained Revenue Growth – The business factors begin with revenue, which grew 50.8% year on year to Rs 4,979 Cr. Revenue has also risen in each of the last 4 quarters, which shows the top line in the Torrent Pharmaceuticals Q2 Results FY27 continued an existing upward sequence.

Return on Equity – Return on equity was 26.76% in FY26. This full-year figure gives context for how the company earned on shareholder funds before the current quarter, separate from the net profit decline seen in these quarterly results.

Return on Capital Employed – Return on capital employed was 19.27% in FY26. Read alongside the 53.83% rise in Operating Profit, it frames the business before interest, tax and other items affected the final net profit figure.

FY27 Outlook After Torrent Pharmaceuticals Q2 Results

This results analysis points to an FY27 outlook that depends on the remaining two quarters. Full-year results will be shaped by what the company reports for October to December and January to March, along with disclosed sector conditions. One quarter of strong revenue and lower profit does not by itself set the annual direction.

The Torrent Pharmaceuticals Q2 Results FY27 give a revenue base of Rs 4,979 Cr and a net profit base of Rs 534 Cr for comparison. Readers can follow how these figures move in the coming quarters through the Univest app, keeping the risks below in mind.

Key Risks to Watch After Torrent Pharmaceuticals Q2 Results FY27

Lower Net Profit

Net profit fell 9.6% year on year to Rs 534 Cr. With the Torrent Pharmaceuticals Q2 Results FY27 showing revenue up sharply, a falling bottom line means the gains in sales did not carry through to profit for shareholders this quarter.

Narrower Net Margin

Net profit margin narrowed to 10.7% from 17.9% in the comparison quarter. A drop of this size means each rupee of revenue produced less profit, which investors will compare against YoY growth figures in the next filing.

High Debt

Debt is high at 1.76 times total assets in FY26. A balance sheet with this level of borrowing can weigh on profit through finance costs, so it remains a figure to track alongside future quarterly disclosures.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

The Torrent Pharmaceuticals Q2 Results FY27 show consolidated results with revenue of Rs 4,979 Cr and Operating Profit of Rs 1,666 Cr, both higher year on year, while net profit eased to Rs 534 Cr. The narrower margin and high debt are the points to watch. Investors can track the Torrent Pharmaceuticals Q2 Results and future quarterly results on the Univest Screener and should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Torrent Pharmaceuticals Q2 Results FY27

What are Torrent Pharmaceuticals Q2 Results FY27?

Ans. Torrent Pharmaceuticals Q2 Results FY27 show revenue of Rs 4,979 Cr and net profit of Rs 534 Cr for July to September 2026. Alongside this, revenue rose while net profit fell, as the Quick Answer explains.

What is the results date for Torrent Pharmaceuticals Q2 Results FY27?

Ans. Torrent Pharmaceuticals declared its Q2 FY27 quarterly results on 23 October 2026. This results date covers the July to September 2026 quarter, as set out in the opening paragraph above.

What revenue was reported in Torrent Pharmaceuticals Q2 Results FY27?

Ans. Torrent Pharmaceuticals reported Q2 FY27 revenue of Rs 4,979 Cr against Rs 3,302 Cr a year earlier. That equals YoY growth of 50.79%, as shown in the Financial Highlights table.

What net profit was reported in Torrent Pharmaceuticals Q2 Results FY27?

Ans. Torrent Pharmaceuticals Q2 Results FY27 show net profit of Rs 534 Cr compared with Rs 591 Cr in the same quarter last year. This 9.64% decline is covered in the Key Takeaways section.

How much YoY growth did revenue show in Torrent Pharmaceuticals Q2 Results FY27?

Ans. Torrent Pharmaceuticals revenue showed YoY growth of 50.79% in Q2 FY27, reaching Rs 4,979 Cr. Compared with this, Operating Profit grew 53.83%, as the Performance Analysis section shows.

Did net profit rise or fall in Torrent Pharmaceuticals Q2 Results?

Ans. Torrent Pharmaceuticals Q2 Results show net profit fell 9.64% YoY to Rs 534 Cr from Rs 591 Cr. Alongside this, net profit margin narrowed to 10.7% from 17.9%, as noted under Key Risks.

What was the Operating Profit in Torrent Pharmaceuticals Q2 Results FY27?

Ans. Torrent Pharmaceuticals reported Operating Profit of Rs 1,666 Cr in Q2 FY27 against Rs 1,083 Cr a year earlier. That is a 53.83% YoY rise, as discussed in the Performance Analysis section.

Are Torrent Pharmaceuticals Q2 Results consolidated results or standalone results?

Ans. Torrent Pharmaceuticals reported its Q2 FY27 numbers on a Consolidated basis. So the revenue of Rs 4,979 Cr and net profit of Rs 534 Cr in this results analysis are consolidated results.

What business factors shaped Torrent Pharmaceuticals Q2 Results FY27?

Ans. Torrent Pharmaceuticals Q2 FY27 was shaped by 50.8% revenue growth and four straight quarters of rising revenue. Alongside these, FY26 return on equity was 26.76%, as listed under Key Business Factors.

What are the key risks after Torrent Pharmaceuticals Q2 Results FY27?

Ans. The key risks after Torrent Pharmaceuticals Q2 Results FY27 are lower net profit, a narrower margin and debt at 1.76 times total assets. Each of these is explained in the Key Risks section.

What is the outlook after Torrent Pharmaceuticals Q2 Results?

Ans. The FY27 picture for Torrent Pharmaceuticals will depend on the December and March quarters. So the Q2 revenue of Rs 4,979 Cr and net profit of Rs 534 Cr act as a base, as the Outlook section notes.

Where can I find the complete Torrent Pharmaceuticals Q2 Results FY27 data?

Ans. The complete Torrent Pharmaceuticals Q2 FY27 figures for revenue, Operating Profit and net profit are in the Financial Highlights table above. Investors can also follow later quarterly results on the Univest Screener.